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ABSTRACT:
 Introduction: Drug utilization research is an important tool to provide facility of rational use of drugs. In low income 
countries irrational use of drugs is a common problem like overuse of drugs and inappropriate use of antibiotics, leading 
to poor treatment outcome and increased burden of treatment. This study was conducted to provide understanding of 
drug utilization pattern by using WHO Core Prescribing Indicator. Methods: This study was conducted in Orthopedics 
and Obstetrics / Gynecology departments. Patients visiting these Out Patient Departments with at least one drug on 
prescription form were included in the study. Further, information related to WHO Core Prescribing Indicators were 
collected in pre-designed proforma. Results: Average number of drugs prescribed per prescription was 2.6. Means of 
number of drugs prescribed in Orthopedics and Obstetrics / Gynecology departments were 2.9 and 2.3 respectively 
(p < 0.001). Drugs prescribed in generic name and from essential drug list was 41.4% and 34.3% respectively. 
Prescription forms with generic name in Orthopedics department were significantly more compared to Obstetrics / 
Gynecology department (p = 0.00002). However, there was an increased tendency to prescribe drugs from essential 
drug list in Obstetrics / Gynecology department compared to Orthopedics department (p < 0.001). Conclusion: Drugs 
were prescribed by generic name and from essential drug list, but this was not sufficient to meet the ideal values of 
WHO Core Prescribing Indicator. Therefore, prioritization on prescribing drugs by generic name and from essential 
drug list by respective departments to achieve the standards of WHO needs to be encouraged. 
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INTRODUCTION:
 Drug utilization research (DUR) is defined 
as “the marketing, distribution, prescription, and 
use of drugs in a society, with special emphasis 
on resulting medical, social and economic 
consequences.”[1] According to WHO estimation, 
more than 50% of drugs are prescribed, dispensed or 
sold irrelevantly.[2] In addition, about one-third of 
the world population do not have access to essential 
drugs.[2,3] In low-income countries, irrational use 
of drugs like overuse of drugs (polypharmacy), 
use of injectable drugs when not necessary and 
unnecessary use of antibiotics in non-bacterial 
infections are common problems.[3,4] This could 
lead to interactions in between drugs, adverse 
outcome of treatment, increased burden of treatment 
cost leading to  mortality of patients.[4] Hence, drug 
utilization studies are usually conducted in healthcare 
providing settings to analyze prescribing trend of 
medicines and to detect whether drugs prescribing 
patterns are rational or irrational.[4] Generally, in 
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Orthopedics and Obstetrics / Gynecology (OBGYN) 
departments, studies are mainly conducted on 
surgical procedures because of topic of interest. 
Only limited studies are available on DUR and 
rational use of drugs worldwide. Similarly, some 
studies have been published in Nepal in various 
departments of tertiary care hospital. However, there 
is insufficiency of literatures. Therefore, this study 
aims to provide understanding of drug utilization 
pattern by using WHO Core Prescribing Indicator 
in Orthopedics and OBGYN departments of tertiary 
care hospital.
METHODS:
 A cross-sectional study was carried out in 
Orthopedics and OBGYN departments of Lumbini 
Medical College (LMC) after permission from 
Institutional Review Committee (IRC-LMC 02-
H/018) of the institute on 19/11/2018. The duration 
of study was three months from 15 November 
2018 to 16 February 2019. The primary data were 
collected from Health Insurance Department for 
about five weeks from 15 November 2018 to 22 
December 2018.
The inclusion criteria were:
• Patient attended Orthopedics and OBGYN 
Out-Patient Departments (OPD) for first time 
• Follow up patient but encountered first time 
by research workers 
• Patient prescribed at least one drug in OPD 
prescription form
The exclusion criteria were:
• Follow up patient encountered previously on 
first visit
• Patient prescribed no drug in OPD 
prescription form
• Patient prescribed herbal medicines in OPD 
prescription form
 Information were retrieved from OPD 
prescription forms and collected in pre-designed 
study proforma. The proforma included demographic 
profile and specific information necessary for 
measuring WHO Core Prescribing Indicator. All the 
information gathered was kept confidential.
Sample size calculation:
• Sample size calculated by using following 
formula:[4]
n = z2 p (1-p) / d2
Where;
p = estimate of proportion with inappropriate 
prescription pattern, 0.5 as there was no 
       research finding related to estimate of 
inappropriate drug utilizing pattern in LMC
n = sample size
d = margin of sampling error tolerated, 0.05
z = standard normal value of confidence interval 
of 95%, that was equal to 1.96
After applying formula, the sample size calculated 
was 384.
The WHO Core Prescribing Indicator was used for 
DUR and calculated as described below:[1,4] 
1. Average number of drugs prescribed 
per encounter to estimate the degree of 
polypharmacy. It was calculated by dividing 
the total number of drugs prescribed by the 
number of encounters done.
2. Percentage of drugs prescribed by generic 
name was calculated to estimate the trend 
of drug prescription by generic name. It was 
calculated by dividing the number of drugs 
prescribed by generic name by total number of 
drugs prescribed, multiplied by 100.
3. Percentage of encounters in which antibiotic 
was prescribed. It was calculated by dividing 
the number of encounters in which an antibiotic 
prescribed by total number of encounters done, 
multiplied by 100.
4. Percentage of encounters with an injection 
prescribed. It was calculated by dividing the 
number of encounters in which an injection 
prescribed by total number of encounters done, 
multiplied by 100.
5. Percentage of drugs prescribed from an 
essential drug list to estimate the degree 
to which practices conform to a National 
Medicine Policy as indicated in the National 
List of Essential Medicines Nepal (Fifth 
revision) 2016.[16] It was calculated by 
dividing number of drugs prescribed which 
were in essential drug list by total number of 
drug prescribed, multiplied by 100. 
All data were entered and coded in EpiData, and 
then analyzed in Statistical Package for the Social 
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Science (SPSS), version 16. Data were presented as 
frequency, percentage, mean, and standard deviation 
(SD). Mean values of continuous variables were 
compared with independent t-test. Categorical 
variables were compared with Chi-square test 
or Fisher-exact test whichever was applicable. P 
value less than 0.05 was considered as statistically 
significant.
RESULT:
 A total of 444 data of patients were enrolled 
during the study period. Equal numbers of records 
were taken from Orthopedics (n = 222) and OBGYN 
(n = 222) OPDs. 81.1% were female and 18.9% were 
male (Table 1). Mean ages of female and male were 
37.4 years (SD = 14.7) and 42.6 years (SD = 19.8) 
respectively. The ages of male were significantly 
higher than female (t [N = 444, df = 105.3] = 2.26, 
p = 0.02). Fracture was the most common diagnosis 
in Orthopedics department (16.2%, n = 222) 
followed by soft tissue injury (15.3%). Likewise, 
pregnancy was the most common condition in 
OBGYN department (34.6%) followed by pelvic 
inflammatory disease (10.8%). Total number of drugs 
prescribed in both departments was 1163. Calcium 
was commonly prescribed (11.5%, n = 1163) in both 
departments followed by pantoprazole (9.8%, n = 
1163). Aceclofenac was commonly prescribed in 
Orthopedics whereas calcium in OBGYN.
 Average number of drugs prescribed in 
prescriptions from both departments was 2.6 
(Table 2). Means of number of drugs prescribed 
in Orthopedics and OBGYN departments were 2.9 
(SD = 1.1) and 2.3 (SD = 1.1) respectively. The 
practice of prescribing number of drugs was slightly 
more in Orthopedics department. However, the 
difference was statistically significant (t [N = 444, 
df = 441.40] = 5.47, p < 0.001). Nearly about half 
of total drugs (n = 1163) were prescribed in generic 
name in both departments (Table 2). Prescription 
forms with generic name in Orthopedics department 
were more than OBGYN. This difference was 
statistically significant (X2 [N = 444, df =1] = 17.72, 
P = 0.00002); Table 3. But, there was an increased 
tendency to prescribe drugs from essential drug list 
in OBGYN department compared to Orthopedics. 
This difference was also statistically significant 
(X2[N = 444, df =1] = 35.11, p < 0.001); Table 3. In 
addition, parenteral drugs were not prescribed very 
commonly both in Orthopedics and OBGYN OPDs. 
However, the tendency of prescribing parenteral 
drugs was slightly more in OBGYN OPDs and the 
difference was statistically significant (X2 [N = 444, 
df = 1] = 10.33, p = 0.001); Table 3.  
DISCUSSION:
 In this study, we aimed to assess drug 
utilization pattern by using WHO core prescribing 
indicators. We found that average numbers of 
Table 1. Socio-demographic characteristics of patients (N = 444)
Characteristics Numbers (%)
Age groups (in years)
        1 ̶ 10  3 (0.7)
      11 ̶ 20 42 (9.4)
      21 ̶ 30 128 (28.9)
      31 ̶ 40   98 (22.0)
      41 ̶ 50    61 (13.8)
      51 ̶ 60    61 (13.8)
          >60    51 (11.4)
Mean age ± SD (in years) 38.4 ± 15.9
Gender
      Female 360 (81.1)
      Male   84 (18.9)
Domicile
      Rural 371 (83.6)
      Urban   73 (16.4)
Prescribing Indicators
Orthopedic and 
OBGYN
(N = 444)
Orthopedic
(n = 222)
OBGYN
(n = 222)
WHO Standard 
Values
Average number of drugs per encounter 2.6  2.9  2.3 1.6  ̶  1.8
% of drugs prescribed by generic name 41.4 47.4  33.8 100%
% of encounters with antibiotic 11.7  5.4 18 20.0  ̶  26.8
% of encounters with injections  3.8  0.9 6.7 13.4 ̶  24.1
% of drugs prescribed from essential drug 
list 34.3 17.2 56 100%
Table 2: WHO Core Prescribing Indicators of drugs
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drug prescribed was marginally above WHO ideal 
value (2.0). Few studies supported our finding and 
showed that there was practice of polypharmacy.
[4,5] Polypharmacy generally means concurrent use 
of more than one drug for a given patient. Since this 
study was conducted at speciality department, so 
this finding could be justifiable. According to WHO, 
average of 44% of drugs are prescribed in generic 
name in Nepal.[1] In our study also near about half 
of total drugs were prescribed in generic name. 
Prescription of drugs by generic name is beneficial 
for rationalization and to decrease cost of drug 
therapy. Besides this, generic prescriptions are clear 
to understand and reduce the risk of error during 
dispensing. In some studies it was found that there 
was zero prescription of drugs by generic name.
Table 3: Comparison of variables between orthopedic and OBGY departments (N = 444)
Variables Orthopedic OBGYN Statistics
Gender
       Female
       Male
140
82
220
2
X2 = 93.96, df = 1,  
P < 0.001
Prescriptions with generic name
      Yes
       No
147
75
103
119
X2 = 17.72, df = 1,  
P = 0.00002
Prescriptions with antibiotic
      Yes
       No
12
210
40
182
X2 = 17.07, df = 1,  
p = 0.00003
Prescriptions with injectable drugs
      Yes
      No
2
220
15
207
X2 = 10.33, df = 1,  
p = 0.001
Prescriptions with drugs from EDL*
      Yes
      No
93
129
155
67
X2 = 35.11, df = 1, 
p < 0.001
Prescriptions with drugs from main list of EDL
      Yes
      No
90
132
148
74
X2 = 30.46, df = 1, 
p < 0.001
Prescriptions with drugs from complementary list of EDL
     Yes
     No
1
221
3
219
Fisher-Exact 
p = 0.623
Prescriptions with drugs from both main and complementary 
list of EDL
     Yes
     No
2
220
4
218
Fisher-Exact  
P = 0.685
Prescriptions with fixed-dose drug combinations
    Yes
    No
24
198
66
156
X2 = 24.58, df = 1 
P < 0.001
*EDL ̶  Essential Drug List
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[6,7,8] However, in few studies about two-third 
to half of total drugs were prescribed by generic 
name.[9,10]. Since many pharmaceutical companies 
develop and manufacture better drugs in terms of 
efficacy and safety, so that they  promote the practice 
of prescribing drugs by brand name among the 
doctors in order to return the cost of manufacturing 
of drugs. This may be the key factor for decreasing 
practice of generic prescription. Although generic 
prescription is always cheaper and more effective, 
this doesn't hold true for each and every drug. 
 Inappropriate prescription of antibiotic can 
potentially lead to antibiotics resistance. Antibiotic 
resistance increases necessity to require more 
costly antibiotics to manage common as well as 
serious type of infections which ultimately increases 
morbidity, mortality and burden of treatment. In 
our study, prescriptions with antibiotics were below 
WHO ideal value. In contrast, some studies showed 
that antibiotics were prescribed in about half to two-
third of total prescriptions form.[11, 12] Antibiotics 
must be used in case of bacterial infections and must 
be reserved for the future otherwise we may lose the 
most powerful tool to treat severe infections in future. 
Regarding essential drugs, they satisfy the priority 
healthcare needs of the patients. General population 
should have access to essential drugs at all time 
in adequate amount at affordable price. In present 
study, approximately one-third of patients prescribed 
drugs from essential drug list. According to WHO, 
100% of drugs should be prescribed from essential 
drug list.[1] Contrary, we have found that more than 
90% of drugs were prescribed from essential drug 
list.[12] While, in support to our study, about one-
third to half of total drugs were prescribed from 
essential drugs list.[13,14,15]. Prescribing drugs 
from essential list is a rational practice. The practice 
of prescription of drugs from essential drug list is not 
sufficient to meet WHO criteria in our tertiary level 
hospital. However, this finding is justifiable because 
in tertiary level hospitals variety of cases are treated 
and only limited drugs are available in essential drug 
list. So it is not always necessary to prescribe drugs 
only from that list.
 The limitation of study is that WHO core 
prescribing indicator highlighted only major problem 
while prescribing drugs. But, it did not show the 
reason of existing problem. Besides this, small 
sample size study was conducted for short duration 
in only one hospital which may not reflect the actual 
scenario of the country. However, we expect that this 
study may create a small basis for carrying study in 
larger sample and for longer duration in future.
CONCLUSION: 
 The study concluded that the average 
number of drugs prescribed in this study was slightly 
over WHO standards. However, the tendency to 
prescribe drugs in generic name and from essential 
drug list didn’t meet the ideal values of WHO drug 
prescribing indicator. So this study emphasizes more 
on prescribing more drugs in generic name and from 
essential drug list to meet standards of WHO.
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